Pliant Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
/ 
Frequently asked questions
To buy Pliant Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pliant Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pliant Therapeutics Inc. is PLRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pliant Therapeutics Inc. has its primary listing on NASDAQ. You can trade Pliant Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pliant Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pliant Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pliant Therapeutics Inc..